Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.280
-0.060 (-4.48%)
At close: Nov 13, 2026, 4:00 PM EST
1.260
-0.020 (-1.56%)
After-hours: Nov 13, 2026, 6:06 PM EST
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $155.61 million as of November 13, 2026. It is the 21,878th most valuable company in the world and the 3,708th biggest in the United States. Its market cap has increased by 29.78% in one year.
Market Cap
155.61M
Enterprise Value
90.97M
1-Year Change
29.78%
Global Rank
Country Rank
#3,708 United States
Category
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $155.61M, an increase of 23.40%. That is a compound annual growth rate of 1.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 155.61M | 37.22% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 227.69M |
| Eledon Pharmaceuticals | 224.50M |
| Korro Bio | 215.90M |
| Cartesian Therapeutics | 210.17M |
| MediWound | 201.64M |
| Sol-Gel Technologies | 201.35M |
| Artiva Biotherapeutics | 200.70M |
| Compugen | 197.97M |